US medical technology firm Recovery Force has received a $1.8m grant from the US National Institutes of Health to develop and clinically validate a device that aims to prevent occurrence of
We are pleased to invite you to the Annual Gene and Cell Therapy: Quality Developments to Commercialization Summit, scheduled for June 5-6, 2019, in Berlin, Germany.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
